Comments
FDA advisory panel backs J&J TB drug
29.11.2012. | (Reuters) - An advisory panel to the U.S. Food and Drug Administration on Wednesday voted that an experimental Johnson & Johnson drug for multidrug-resistant tuberculosis appears to be safe and effective, but highlighted potential heart and liver-safety issues....
